Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Blas J Larrauri"'
The SARS-CoV-2 virus emerged in December 2019 infecting more than 430 million people worldwide and causing almost 6 million deaths until February 2022. Rapid vaccination efforts during this period coincided with a reduction in the mortality rate of t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1a38142d44aaa03d512663365f1f00aa
https://doi.org/10.1101/2022.05.20.22275396
https://doi.org/10.1101/2022.05.20.22275396
Autor:
Alejandro Malbrán, Blas J Larrauri
Publikováno v:
Medicina (Buenos Aires), Vol 79, Iss 1, Pp 76-77 (2019)
Publikováno v:
Medicina. 76(6)
Most studies about treatment of inflammatory myopathies consist of cross-sectional analyses that do not assess long-term efficacy. In the present study we describe the follow-up of seven patients with inflammatory myopathies, 5 polymyositis and 2 der
Autor:
Eloisa, Malbrán, Diego, Fernández Romero, Maria Cecilia, Juri, Blas J, Larrauri, Alejandro, Malbrán
Publikováno v:
Medicina. 75(5)
We describe the diagnostic epidemiology, the clinical course, the family history and the response to treatment of patients with angioedema without wheals (AWW) at an Allergy and Immunology Clinical Center. We reviewed the case records of all patients
Autor:
Diego S, Fernández Romero, María Gabriela, Torre, Blas J, Larrauri, Eloisa, Malbrán, María Cecilia, Juri, Alejandro, Malbrán
Publikováno v:
Medicina. 75(5)
Rituximab, a chimeric monoclonal antibody against CD20, induces the depletion of B lymphocytes. It is used for the treatment of lymphoproliferative and autoimmune diseases. Antibody immunodeficiency associated to RTX treatment is a new motif for cons
Autor:
Diego S. Fernández Romero, Blas J. Larrauri, Alejandro Malbrán, Eloisa Malbrán, María Cecilia Juri
Publikováno v:
Journal of Allergy and Clinical Immunology. 135:AB199
Publikováno v:
Journal of Allergy and Clinical Immunology. 131:AB70